Confusarin is used in neuropharmacological research due to its potent convulsant properties, particularly for studying effects on the central nervous system. It induces clonic-tonic seizures in animal models at low doses and is investigated for its interactions with neurotransmitter systems, such as GABAergic pathways involved in neuronal excitation and inhibition. This compound aids in understanding mechanisms underlying epilepsy and other seizure-related disorders. It shows potential as a research tool for developing CNS therapeutics, though commercial applications are limited by its specificity to experimental contexts and challenges in large-scale production.